A randomized, controlled, double-blind study of light emitting diode photomodulation for the prevention of radiation dermatitis in patients with breast cancer

Dermatologic Surgery

Volumn 36, Issue 12, 2010, Pages 1921-1927

  Fife, Douglas ^a   Rayhan, David J ^b   Behnam, Shahdad ^a   Ortiz, Arisa ^a   Elkeeb, Laila ^a   Aquino, Lisa ^b   Eduardo Roa, D ^b   Ramsinghani, Nilam ^b   Kuo, Jeffrey ^b   Newcomb, Robert ^c   Zachary, Christopher B ^a   Kelly, Kristen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Ringgold Standard Institution Informatics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRY SKIN; ERYTHEMA; HUMAN; LIGHT EMITTING DIODE; PATIENT SATISFACTION; PHOTOTHERAPY; PRIORITY JOURNAL; RADIATION DERMATITIS; RANDOMIZED CONTROLLED TRIAL; SKIN EDEMA; SKIN EXFOLIATION; SKIN MANIFESTATION; SKIN NECROSIS; SKIN ULCER; TREATMENT OUTCOME; TREATMENT RESPONSE;

BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; PHOTOTHERAPY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RADIODERMATITIS; THERMOLUMINESCENT DOSIMETRY; TREATMENT OUTCOME;

EID: 78650032448     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01801.x     Document Type: Article

References (18)

1. Fisher J, Scott C, Stevens R, et al,. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: radiation therapy oncology group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000; 48: 1307-10.
2. Hymes SR, Strom EA, Fife C., Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006; 54: 28-46.
3. Weiss RA, McDaniel DH, Geronemus RG, Weiss MA., Clinical trial of a novel non-thermal LED array for reversal of photoaging: clinical, histologic, and surface profilometric results. Lasers Surg Med 2005; 36: 85-91.
4. Weiss RA, Weiss MA, Geronemus RG, McDaniel DH., A novel non-thermal non-ablative full panel LED photomodulation device for reversal of photoaging: digital microscopic and clinical results in various skin types. J Drugs Dermatol 2004; 3: 605-10.
5. Geronemus R, McDaniel DH, Weiss R, Weiss M., LED photomodulation "reverses" acute UV induced matrix enzyme expression. Abstract 77. American Society for Laser Medicine and Surgery Abstracts. April, 2006
6. McDaniel DH, Geronemus RG, Weiss M, Weiss RA., LED photomodulation accelerates wound healing of acute skin injury. Abstract 107. American Society for Laser Medicine and Surgery Abstracts. April, 2006
7. McDaniel DH, Weiss RA, Geronemus R, et al,. Light-tissue interactions 1: photothermolysis vs photomodulation laboratory findings. Lasers Surg Med 2002; 14: 25.
8. Weiss RA, McDaniel DH, Geronemus RG, et al,. Clinical experience with light-emitting diode (LED) photomodulation. Dermatol Surg 2005; 31 (9 Pt 2): 1199-205.
9. DeLand MM, Weiss RA, McDaniel DH, Geronemus RG., Treatment of radiation-induced dermatitis with light-emitting diode (LED) photomodulation. Lasers Surg Med 2007; 39: 164-8.
10. McDaniel DH, Newman J, Geronemus R, et al,. Non-ablative non-thermal LED photomodulation-a multicenter clinical photoaging trial. Lasers Surg Med 2003; 15: 22.
11. Barolet D, Boucher A,. LED photoprevention: reduced MED response following multiple LED exposures. Lasers Surg Med 2008; 40: 106-12.
12. Frank S, Menezes S, Lebreton-De Coster C, et al,. Infrared radiation induces the p53 signaling pathway: Role in infrared prevention of ultraviolet B toxicity. Exp Dermatol 2006; 15: 130-137.
13. Harper JL, Franklin LE, Jenrette JM, Aguero EG., Skin toxicity during breast irradiation: pathophysiology and management. South Med J 2004; 97: 989-93.
14. Iannuzzi CM, Atencio DP, Green S, et al,. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 2002; 52: 606-13.
15. Harsolia A, Kestin L, Grills I, et al,. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1375-80.
16. Donovan E, Bleakley N., Breast Technology Group et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007; 82: 254-64.
17. Pignol JP, Olivotto I, Rakovitch E, et al,. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26: 2085-92.
18. Haffty BG, Buchholz TA, McCormick B., Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient? J Clin Oncol 2008; 26: 2072-4.